Q2 FY22 Results: Mytheresa Reports Strong GMV Growth of 26.2% in Q2 FY22 and Increases Guidance for Full Fiscal Year 2022
MYT Netherlands Parent B.V. (NYSE: MYTE) reported strong Q2 FY22 results with Gross Merchandise Value (GMV) growth of 26.2% to €200.2 million compared to the previous year. Net sales rose 18.3% to €187.6 million, while adjusted EBITDA increased 27.8% to €28.3 million. The company also highlighted a 390 basis points increase in gross profit margin, reaching 53.4%. With strong growth in the US market and a rise in active customers by 30.2%, Mytheresa is confident in its future outlook, raising guidance for GMV to between €755 million and €775 million.
- GMV growth of 26.2% year-over-year to €200.2 million.
- Net sales increase of 18.3% year-over-year to €187.6 million.
- Adjusted EBITDA growth of 27.8% to €28.3 million.
- Gross profit margin increased by 390 basis points to 53.4%.
- Active customer growth of 30.2%, reaching 740,000 customers.
- Strong sales growth in the US market with 74.2% increase.
- None.
-
Gross Merchandise Value (GMV) growth of
26.2% to€200.2 million in Q2 FY22, compared to€158.6 million in Q2 FY21 -
Top-line strength evident by the two-year GMV growth of
67.7% in Q2 FY22 vs. Q2 FY20 -
Net sales increase of
18.3% year-over-year to€187.6 million -
Continued strong profitability with adjusted EBITDA of
€28.3 million compared to€22.1 million in Q2 FY21, representing27.8% growth
Kliger continued, “Furthermore, we are gaining traction as a top of mind shopping destination for luxury consumers in
FINANCIAL HIGHLIGHTS FOR THE SECOND QUARTER ENDED
-
GMV increase of
26.2% year-over-year to€200.2 million , as compared to€158.6 million in the prior year period -
Net sales increase of
18.3% year-over-year to€187.6 million -
Increase of 390 basis points gross profit margin to
53.4% compared to49.5% in the prior year period due to the increase in full price business and sales from the CPM generating100% gross margin -
Adjusted EBITDA of
€28.3 million , as compared to€22.1 million in the prior year period -
Increase of adjusted EBITDA margin to
15.1% from14.0% in Q2 FY21 -
Adjusted operating income of
€26.0 million , as compared to€20.1 million in the prior year period -
Adjusted net income of
€18.9 million , as compared to€14.8 million in the prior year period
RECENT BUSINESS HIGHLIGHTS
Strong Global Expansion:
-
Strong GMV growth across all geographies with +
26.2% vs. Q2 FY21 and +67.7% vs. Q2 FY20 -
Strongest net sales growth again in
the United States with +74.2% vs. Q2 FY21 as market penetration accelerates -
High-impact top customer events held in
Europe ,China andthe United States
Continued Brand Partnerships:
-
Launch of exclusive capsule collections and pre-launches in collaboration with
Tom Ford ,Isabel Marant , Givenchy,Acne Studios ,Ami Paris ,Christian Louboutin , Bottega Veneta and many more - Successful roll-out of the Curated Platform Model (CPM) to now 6 brands with positive business impact
-
First ever 360° virtual reality pop-up produced for Moncler exclusives’ launch on
Mytheresa
High-quality Customer Growth:
-
LTM growth of active customers of
30.2% reaching 740,000 customers - New record number of new first-time buyers in one quarter with over 120,000 customers
- Continued positive repurchase rates of newly acquired customer cohorts in Q2 FY22
-
Strong growth of number of top customers with
39.6% in Q2 FY22 vs. Q2 FY21 as well as increase in average GMV per top customers with2.3% in Q2 FY22 vs. Q2 FY21 - Launch of carbon offsetting option for our customers when ordering in addition to Mytheresa’s commitment to reach carbon neutrality with FY22
Consistent Strong Operational Performance:
-
Maintained business continuity in all operations despite Omicron virus wave, with focus on health and well-being of all
Mytheresa employees as top priority -
Very high customer satisfaction with a Net Promoter Score of
82.2% in Q2 FY22 despite global shipping delays -
Achieved strong gross profit margin with
53.4% in Q2 FY22 based on consistent focus on full-price business and sales from the CPM generating100% gross margin -
Start of construction of new warehouse at
Leipzig Airport ,Germany , with expected significant improvements in delivery times
BUSINESS OUTLOOK
For the full fiscal year ending
-
GMV in the range of
€755 million to€775 million , representing a23% to26% growth (up from€750 million to€770 million , representing a22% to25% growth) -
Net sales at
€700 million to€720 million (confirmed€700 million to€720 million ) -
Gross profit at
€350 million to€365 million , representing a22% to27% growth (up from€345 million to€355 million , representing a21% to24% growth) -
Adjusted EBITDA margin in the range of
9% to10% (up from8% to9% )
The foregoing forward-looking statements reflect Mytheresa’s expectations as of today's date. Given the number of risk factors, uncertainties and assumptions discussed below, actual results may differ materially.
CONFERENCE CALL AND WEBCAST INFORMATION
FORWARD LOOKING STATEMENTS
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements relating to the impact of the COVID-19 global pandemic; the impact of restrictions on use of identifiers for advertisers (IDFA); future sales, expenses, and profitability; future development and expected growth of our business and industry; our ability to execute our business model and our business strategy; having available sufficient cash and borrowing capacity to meet working capital, debt service and capital expenditure requirements for the next twelve months; and projected capital spending. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements are only predictions. Actual events or results may differ materially from those stated or implied by these forward-looking statements. In evaluating these statements and our prospects, you should carefully consider the factors set forth below.
We undertake no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.
The achievement or success of the matters covered by such forward-looking statements involves known and unknown risks, uncertainties and assumptions. If any such risks or uncertainties materialize or if any of the assumptions prove incorrect, our results could differ materially from the results expressed or implied by the forward-looking statements we make.
You should not rely upon forward-looking statements as predictions of future events. Forward-looking statements represent our management’s beliefs and assumptions only as of the date such statements are made.
Further information on these and other factors that could affect our financial results is included in filings we make with the
ABOUT NON-IFRS FINANCIAL MEASURES AND OPERATING METRICS
We review a number of operating and financial metrics, including the following business and non-IFRS metrics, to evaluate our business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions. We present Adjusted EBITDA, Adjusted Operating Income and Adjusted Net Income because they are frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Further, we believe these measures are helpful in highlighting trends in our operating results, because they exclude the impact of items that are outside the control of management or not reflective of our ongoing operations and performance. Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income have limitations, because they exclude certain types of expenses. We use Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income as supplemental information only. You are encouraged to evaluate each adjustment and the reasons we consider it appropriate for supplemental analysis.
Our non-IFRS financial measures include:
- Adjusted EBITDA is a non-IFRS financial measure that we calculate as net income before finance expense (net), taxes, and depreciation and amortization, adjusted to exclude IPO preparation and transaction costs, other transaction-related costs and IPO-related share-based compensation expenses.
- Adjusted Operating Income is a non-IFRS financial measure that we calculate as operating income, adjusted to exclude IPO preparation and transaction costs, other transaction-related costs and IPO-related share-based compensation expenses.
- Adjusted Net Income is a non-IFRS financial measure that we calculate as net income, adjusted to exclude finance expenses on our Shareholder Loans, IPO preparation and transaction costs, other transaction-related costs, IPO-related share-based compensation expenses and related income tax effects.
We are not able to forecast net income (loss) on a forward-looking basis without unreasonable efforts due to the high variability and difficulty in predicting certain items that affect net income (loss), including, but not limited to, Income taxes and Interest expense and, as a result, are unable to provide a reconciliation to forecasted Adjusted EBITDA.
Gross Merchandise Value (GMV) is an operative measure and means the total Euro value of orders processed. GMV is inclusive of merchandise value, shipping and duty. It is net of returns, value added taxes and cancellations. GMV does not represent revenue earned by us. We use GMV as an indicator for the usage of our platform that is not influenced by the mix of direct sales and commission sales. The indicators we use to monitor usage of our platform include, among others, active customers, total orders shipped and GMV.
ABOUT
Source:
Financial Results and Key Operating Metrics
(Amounts in € millions)
|
Three Months Ended |
|
Six Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change
|
|
|
|
|
|
Change
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
Gross Merchandise Value (GMV) |
|
|
|
|
|
|
|
|
|
|
|
Active customer (LTM in thousands) |
569 |
|
740 |
|
|
|
569 |
|
740 |
|
|
Total orders shipped (LTM in thousands) |
1,256 |
|
1,656 |
|
|
|
1,256 |
|
1,656 |
|
|
Net sales |
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
|
|
|
|
|
|
|
|
|
Gross profit margin(1) |
|
|
|
|
390 BPs |
|
|
|
|
|
320 BPs |
Adjusted EBITDA(2) |
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA margin(1,2) |
|
|
|
|
110 BPs |
|
|
|
|
|
90 BPs |
Adjusted Operating Income (2) |
|
|
|
|
|
|
|
|
|
|
|
Adjusted Operating Income margin(1,2) |
|
|
|
|
120 BPs |
|
|
|
|
|
100 BPs |
Adjusted Net Income(2) |
|
|
|
|
|
|
|
|
|
|
|
Adjusted Net Income margin(1,2) |
|
|
|
|
80 BPs |
|
|
|
|
|
80 BPs |
(1) As a percentage of net sales.
(2) EBITDA, adjusted EBITDA, adjusted Operating Income, adjusted net income are measures not defined under IFRS. For further information about how we calculate these measures and limitations of its use, see above.
Financial Results and Key Operating Metrics
(Amounts in € millions)
The following are reconciliations of Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income to their most directly comparable IFRS financial measures:
|
Three Months Ended |
|
Six Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change
|
|
|
|
|
|
Change
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
( |
|
|
|
|
|
( |
Finance expenses, net |
|
|
|
|
( |
|
|
|
|
|
( |
Income tax expense |
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
thereof depreciation of right- of use assets |
|
|
|
|
|
|
|
|
|
|
|
EBITDA |
|
|
|
|
( |
|
|
|
|
|
( |
IPO preparation and transaction costs(1) |
|
|
|
|
( |
|
|
|
|
|
( |
Other transaction-related costs(2) |
|
|
|
|
N/A |
|
|
|
|
|
N/A |
IPO related share-based compensation(3) |
|
|
|
|
N/A |
|
|
|
|
|
N/A |
Adjusted EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change
|
|
|
|
|
|
Change
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
Operating Income |
|
|
|
|
( |
|
|
|
|
|
( |
IPO preparation and transaction costs(1) |
|
|
|
|
( |
|
|
|
|
|
( |
Other transaction-related costs(2) |
|
|
|
|
N/A |
|
|
|
|
|
N/A |
IPO related share-based compensation(3) |
|
|
|
|
N/A |
|
|
|
|
|
N/A |
Adjusted Operating Income |
|
|
|
|
|
|
|
|
|
|
|
Financial Results and Key Operating Metrics
(Amounts in € millions)
|
Three Months Ended |
|
Six Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change
|
|
|
|
|
|
Change
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
Net Income |
|
|
|
|
( |
|
|
|
|
|
( |
IPO preparation and transaction costs(1) |
|
|
|
|
( |
|
|
|
|
|
( |
Other transaction-related costs(2) |
|
|
|
|
N/A |
|
|
|
|
|
N/A |
IPO related share-based compensation(3) |
|
|
|
|
N/A |
|
|
|
|
|
N/A |
Finance expenses on shareholder loans(4) |
|
|
|
|
( |
|
|
|
|
|
( |
Income tax effect(5) |
|
|
|
|
( |
|
|
|
|
|
( |
Adjusted Net Income |
|
|
|
|
|
|
|
|
|
|
|
(1) Represents non-recurring professional fees, including consulting, legal and accounting fees, related to our initial public offering, which are classified within selling, general and administrative expenses.
(2) Other transaction-related costs represents non-recurring professional fees, including advisory and accounting fees, related to potential transactions.
(3) In fiscal 2021, with the effective IPO, certain key management personnel received a one-time granted share-based compensation, for which the share-based compensation expense will be recognized upon defined vesting schedules in the future periods, including
(4) Our Adjusted Net Income excludes finance income (expenses) associated with our Shareholder Loans, which we do not consider to be indicative of our core performance. We did not receive any cash proceeds under the Shareholder Loans, which originated as part of the
(5) Reflects adjustments to historical income tax expense to reflect changes in taxable income for each of the periods presented due to changes in finance expenses related to the Shareholder Loans, assuming a statutory tax rate of
Unaudited Condensed Consolidated Statements of Profit and Comprehensive Income
(Amounts in € thousands, except share and per share data)
|
|
|
Three Months Ended |
|
Six Months Ended |
||||
|
|
|
|
|
|
|
|
||
(in € thousands) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
|
158,593 |
|
187,571 |
|
284,952 |
|
345,402 |
Cost of sales, exclusive of depreciation and amortization |
|
|
(80,023) |
|
(87,453) |
|
(147,701) |
|
(167,969) |
Gross profit |
|
|
78,570 |
|
100,118 |
|
137,251 |
|
177,433 |
Shipping and payment cost |
|
|
(17,833) |
|
(25,509) |
|
(32,666) |
|
(45,476) |
Marketing expenses |
|
|
(19,696) |
|
(23,828) |
|
(37,137) |
|
(46,256) |
Selling, general and administrative expenses |
|
|
(22,104) |
|
(40,980) |
|
(37,660) |
|
(77,138) |
Depreciation and amortization |
|
|
(2,046) |
|
(2,261) |
|
(4,067) |
|
(4,443) |
Other expense (income), net |
|
|
(276) |
|
1,708 |
|
(897) |
|
1,427 |
Operating income |
|
|
16,615 |
|
9,246 |
|
24,824 |
|
5,547 |
Finance income |
|
|
7,952 |
|
0 |
|
16,243 |
|
0 |
Finance costs |
|
|
(2,976) |
|
(199) |
|
(6,085) |
|
(388) |
Finance income (costs), net |
|
|
4,975 |
|
(199) |
|
10,157 |
|
(388) |
Income (loss) before income taxes |
|
|
21,590 |
|
9,048 |
|
34,981 |
|
5,159 |
Income tax expense |
|
|
(5,866) |
|
(6,982) |
|
(9,627) |
|
(10,390) |
Net income (loss) |
|
|
15,724 |
|
2,066 |
|
25,354 |
|
(5,230) |
Cash Flow Hedge |
|
|
78 |
|
(1,088) |
|
949 |
|
(2,169) |
Income Taxes related to Cash Flow Hedge |
|
|
11 |
|
336 |
|
(231) |
|
604 |
Foreign currency translation |
|
|
- |
|
(28) |
|
- |
|
(54) |
Other comprehensive income (loss) |
|
|
89 |
|
(780) |
|
718 |
|
(1,619) |
Comprehensive income (loss) |
|
|
15,813 |
|
1,287 |
|
26,072 |
|
(6,849) |
|
|
|
|
|
|
|
|
|
|
Basic & diluted earnings per share |
|
€ |
0.22 |
€ |
0.02 |
|
0.36 |
€ |
(0.06) |
Weighted average ordinary shares outstanding (basic) - in millions |
|
|
70.2 |
|
86.3 |
|
70.2 |
|
86.3 |
Weighted average ordinary shares outstanding (diluted) - in millions |
|
|
70.2 |
|
87.7 |
|
70.2 |
|
88.0 |
Unaudited Condensed Consolidated Statements of Financial Position
(Amounts in € thousands)
(in € thousands) |
|
|
|||
Assets |
|||||
Non-current assets |
|||||
Intangible assets and goodwill |
155,611 |
155,353 |
|||
Property and equipment |
|
|
8,810 |
|
8,411 |
Right-of-use assets |
14,009 |
21,328 |
|||
Total non-current assets |
178,430 |
185,091 |
|||
Current assets |
|
|
|||
Inventories |
|
|
247,054 |
|
244,312 |
Trade and other receivables |
5,030 |
41,814 |
|||
Other assets |
|
|
14,667 |
|
17,535 |
Cash and cash equivalents |
76,760 |
79,745 |
|||
Total current assets |
|
|
343,510 |
|
383,406 |
Total assets |
521,941 |
568,497 |
|||
|
|
||||
Shareholders’ equity and liabilities |
|
|
|||
Subscribed capital |
1 |
1 |
|||
Capital reserve |
|
|
444,951 |
|
477,424 |
Accumulated Deficit |
(60,837) |
(66,067) |
|||
Accumulated other comprehensive income |
|
|
1,602 |
|
(17) |
Total shareholders’ equity |
385,718 |
411,342 |
|||
|
|
||||
Non-current liabilities |
|
|
|
|
|
Provisions |
|
|
717 |
|
742 |
Lease liabilities |
8,786 |
16,063 |
|||
Deferred tax liabilities |
|
|
2,308 |
|
4,806 |
Total non-current liabilities |
11,811 |
21,611 |
|||
Current liabilities |
|
|
|
|
|
Tax liabilities |
|
|
14,293 |
|
19,906 |
Lease liabilities |
|
|
5,361 |
|
5,443 |
Contract liabilities |
10,975 |
8,314 |
|||
Trade and other payables |
|
|
43,558 |
|
39,170 |
Other liabilities |
50,225 |
62,711 |
|||
Total current liabilities |
|
|
124,412 |
|
135,544 |
Total liabilities |
136,223 |
157,156 |
|||
Total shareholders’ equity and liabilities |
|
|
521,941 |
|
568,497 |
Unaudited Condensed Consolidated Statements of Changes in Equity
(Amounts in € thousands)
(in € thousands) |
|
Subscribed capital |
|
Capital reserve |
|
Accumulated deficit |
|
Hedging reserve |
|
Foreign currency translation reserve |
|
Total shareholders’ equity |
Balance as of |
|
1 |
|
91,008 |
|
(28,234) |
|
- |
|
1,602 |
|
64,377 |
Net income |
|
- |
|
- |
|
25,354 |
|
- |
|
- |
|
25,354 |
Other comprehensive income |
|
- |
|
- |
|
- |
|
718 |
|
- |
|
718 |
Comprehensive income |
|
- |
|
- |
|
25,354 |
|
718 |
|
- |
|
26,072 |
Share-based compensation |
|
- |
|
14 |
|
|
|
- |
|
|
|
14 |
Balance as of |
|
1 |
|
91,022 |
|
(2,880) |
|
718 |
|
1,602 |
|
90,463 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of |
|
1 |
|
444,951 |
|
(60,837) |
|
- |
|
1,602 |
|
385,718 |
Net income |
|
- |
|
- |
|
(5,230) |
|
- |
|
- |
|
(5,230) |
Other comprehensive income |
|
- |
|
- |
|
- |
|
(1,566) |
|
(53) |
|
(1,619) |
Comprehensive income |
|
- |
|
- |
|
(5,230) |
|
(1,566) |
|
(53) |
|
(6,849) |
Share-based compensation |
|
- |
|
32,473 |
|
- |
|
- |
|
- |
|
32,473 |
Balance as of |
|
1 |
|
477,424 |
|
(66,067) |
|
(1,566) |
|
1,549 |
|
411,342 |
Unaudited Condensed Consolidated Statements of Cash Flows
(Amounts in € thousands)
Six months ended |
|||||
(in € thousands) |
2020 |
2021 |
|||
Net income (loss) |
|
|
25,354 |
|
(5,230) |
Adjustments for |
|
|
|
|
|
Depreciation and amortization |
|
|
4,067 |
|
4,443 |
Finance (income) costs, net |
|
|
(10,157) |
|
388 |
Share-based compensation |
|
|
14 |
|
32,473 |
Income tax expense |
|
|
9,627 |
|
10,390 |
Change in operating assets and liabilities |
|
|
|
|
|
Increase (decrease) in provisions |
|
|
124 |
|
25 |
(Increase) decrease in inventories |
|
|
(62,837) |
|
2,741 |
(Increase) decrease in trade and other receivables |
|
|
(1,197) |
|
(36,785) |
Decrease (increase) in other assets |
|
|
1,955 |
|
(2,817) |
(Decrease) increase in other liabilities |
|
|
2,968 |
|
10,267 |
Increase (decrease) in contract liabilities |
|
|
(734) |
|
(2,661) |
Increase (decrease) in trade and other payables |
|
|
2,550 |
|
(4,387) |
Income taxes paid |
|
|
(1,102) |
|
(1,674) |
Net cash provided by (used in) operating activities |
|
|
(29,368) |
|
7,172 |
Expenditure for property and equipment and intangible assets |
|
|
(1,363) |
|
(1,057) |
Proceeds from sale of property and equipment and intangible assets |
|
|
44 |
|
- |
Net cash (used in) investing activities |
|
|
(1,319) |
|
(1,057) |
Interest paid |
|
|
(3,962) |
|
(388) |
Proceeds from bank liabilities |
|
|
64,990 |
|
- |
Repayment of liabilities from banks |
|
|
(29,000) |
|
- |
Repayment of Shareholder loans |
|
|
(2,411) |
|
- |
Payment of lease liabilities |
|
|
(3,047) |
|
(2,689) |
Net cash (used in) provided by financing activities |
|
|
26,570 |
|
(3,076) |
Net increase (decrease) in cash and cash equivalents |
|
|
(4,118) |
|
3,038 |
Cash and cash equivalents at the beginning of the period |
|
|
9,367 |
|
76,760 |
Effects of exchange rate changes on cash and cash equivalents |
|
|
(18) |
|
(53) |
Cash and cash equivalents at end of the period |
|
|
5,231 |
|
79,745 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220216005133/en/
Investor Relations Contacts
phone: +49 89 127695-1919
email: investors@mytheresa.com
Solebury Trout
phone: +1 800 929 7167
email: investors@mytheresa.com
Media Contacts for public relations
mobile: +49 152 54725178
phone: +49 89 127695-236
email: sandra.romano@mytheresa.com
Media Contacts for business press
mobile: +49 152 38297355
phone: +49 89 127695-1358
email: alberto.fragoso@mytheresa.com
Source:
FAQ
What were MYTE's Q2 FY22 financial highlights?
How did Mytheresa's performance in the US market evolve in Q2 FY22?
What changes were made to Mytheresa's business outlook for FY22?